As medicine evolves so too does our understanding of disease progression and, increasingly, the role of biomarkers in predicting patients at increased risk of disease progression.
Join our host Dr Joe Kosterich with endocrinologist Professor Tim Davis, general surgeon Dr Bill Gong and chemical pathologist Dr Johan Conradie to learn more about how predictive biomarkers are changing our understanding of diabetes-related kidney disease and oesophageal cancer.
Understand how blood-based predictive tests can be used for identifying patients with diabetes at risk of declining kidney function, including those with currently normal renal markers, and also for assessing progression risk in patients with Barrett's oesophagus.
Learn more about the clinical assessment of chronic reflux, appropriate investigation and referral, and the potential role of biomarkers in guiding surveillance of your patients.
Improve your understanding of emerging diagnostic tools, their interpretation and limitations, and their potential to support earlier risk identification and evidence-based clinical decision-making in primary care.